Villaroya, Guillerma O.

HRN: 19-46-10  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/17/2022
12/19/2022
IV
600mg
Q6
Sepsis, DM Foot, Cellulitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: